Center for Values, Ethics and the Law in Medicine, University of Sydney
Parker L, Carter SM, Williams J, Pickles K, Barratt A.
Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices. Eur J Cancer. 2017;85:1-5. Parker L.
Including values in evidence-based policy making for breast screening: An empirically grounded tool to assist expert decision makers. Health Policy. 2017;121(7):793-9. Williams J, Carter SM, Rychetnik L.
Contested Guideline Development in Australia’s Cervical Screening Program: Values Drive Different Views of the Purpose and Implementation of Organized Screening. Public Health Ethics. 2017;10(1):5-18. Degeling C, Rychetnik L, Street J, Thomas R, Carter SM.
Influencing health policy through public deliberation: Lessons learned from two decades of Citizens’/community juries. Soc Sci Med. 2017;179:166-71. Carter SM.
Overdiagnosis, ethics, and trolley problems: why factors other than outcomes matter—an essay by Stacy Carter. BMJ. 2017;358:j3872. (With a podcast.) Carter SM.
Overdiagnosis: an important issue that demands rigour and precision: Comment on Medicalisation and overdiagnosis: what society does to medicine. Int J Health Policy Manag. 2017;6(Published online: 25 February 2017). Carter SM, Barratt A.
What is overdiagnosis and why should we take it seriously in cancer screening? Public Health Research & Practice. 2017;27(3):e2731722. McGill S, Carter SM.
Cancer screening: concerns, controversy and evidence. Public Health Research & Practice. 2017;27(3):e2731720. Armstrong BK BM, Frydenberg M, Gardiner RA, Haines I, Carter SM.
PSA testing for men at average risk of prostate cancer. Public health research and practice. 2017;27(3):e2731721. Carter SM, Degeling C, Doust J, Barratt A.
A definition and ethical evaluation of overdiagnosis. J Med Ethics. 2016;42(11):705-14. Carter SM, Doust J, Degeling C, Barratt A.
A definition and ethical evaluation of overdiagnosis: response to commentaries. J Med Ethics. 2016;42:722-4. Williams JH, Carter SM.
An empirical study of the ‘underscreened’ in organised cervical screening: experts focus on increasing opportunity as a way of reducing differences in screening rates. BMC Medical Ethics. 2016;17(1):1-12. Pickles K, Carter SM, Rychetnik L, McCaffery K, Entwistle V.
General Practitioners’ Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study. PLoS ONE. 2016;11(4):e0153299. Pickles K, Carter SM, Rychetnik L, Entwistle VA.
Doctors’ perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study. BMJ Open. 2016;6(12):e011932. Parker LM, Carter SM.
The Role of Socially Embedded Concepts in Breast Cancer Screening: An Empirical Study with Australian Experts. Public Health Ethics. 2016;9(3):276–89. Jacklyn G, Glasziou P, Macaskill P, Barratt A.
Meta-analysis of breast cancer mortality benefit and over diagnosis adjusted for adherence: improving information on the effects of attending screening mammography. British Journal of Cancer. 2016; Apr 28. doi: 1038/bjc.2016.90. [Epub ahead of print] Degeling C, Carter SM, Rychetnik L.
All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer. Health. 2016;20(5):465-84. Carter SM.
Ethical aspects of cancer screening. Cancer Forum. 2016;40(2):105-9. Barratt A, Jacklyn GL. Challenges in Understanding and Quantifying Overdiagnosis and Overtreatment. In: Houssami N, Miglioretti D, editors.
London, UK: Elsevier; 2016. Breast Cancer Screening: An Examination of Scientific Evidence. Parker L, Carter SM. Ethical and social issues in breast cancer screening. In: N. Houssami, D Miglioretti (editors),
(pp. 347-374) London, UK: Elsevier; 2016. Breast cancer screening: an examination of scientific evidence. McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, et al.
Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ. 2016;352:i348. Parker LM, Rychetnik L, Carter SM.
The role of communication in breast cancer screening: a qualitative study with Australian experts. BMC Cancer. 2015 15(Oct 19):741. Pickles K, Carter SM, Rychetnik L.
Doctors’ approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study. BMJ open. 2015;5(3):e006367. Parker LM, Rychetnik L, Carter S.
Framing overdiagnosis in breast screening: a qualitative study with Australian experts. BMC Cancer. 2015;15(1):1-8. Barratt A.
Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality. BMJ. 2015;350:h867. Parker L, Rychetnik L, Carter S.
Values in breast cancer screening: an empirical study with Australian experts. BMJ open. 2015;5(5):e006333. Degeling C, Rychetnik L, Pickles K, Thomas R, Doust JA, Gardiner RA, et al. “
What should happen before asymptomatic men decide whether or not to have a PSA test?” A report on three community juries. Med J Aust. 2015;203(8):335. Degeling C, Carter SM, Rychetnik L.
Which public and why deliberate? – A scoping review of public deliberation in public health and health policy research. Soc Sci Med. 2015;131:114-21. Carter SM, Williams J, Parker L, Pickles K, Jacklyn G, Rychetnik L, et al.
Screening for Cervical, Prostate, and Breast Cancer: Interpreting the evidence. Am J Prev Med. 2015;49(2):274–85. Carter SM, Rogers W, Heath I, Degeling C, Doust J, Barratt A.
The challenge of overdiagnosis begins with its definition. BMJ. 2015;350:doi 10.1136/bmj.h869. (With a podcast.) Williams JH, Carter SM, Rychetnik L.
‘Organised’ cervical screening 45 years on: How consistent are organised screening practices? Eur J Cancer. 2014;50(17):3029-38. Williams JH, Carter SM, Rychetnik L.
Information provision in cervical screening in Australia. Med J Aust. 2014;201(5):295-7. Carter SM. Cancer Prevention Services, Utilization of. In: Cockerham WC, Dingwall R, Quah SR, editors. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society: John Wiley & Sons, Ltd; 2014. p. 190–2.
Rychetnik L, Carter SM, Barratt A, Irwig L.
Expanding the evidence on cancer screening: the value of scientific, social and ethical perspectives. The Medical journal of Australia. 2013;198(10):536-9. Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, et al.
Enhancing Citizen Engagement in Cancer Screening Through Deliberative Democracy. J Natl Cancer Inst. 2013;105(6):380-6. Thesis: Jane Hannah Williams.
An empirical ethics analysis of cervical screening organisation 15-Jun-2016 Thesis: Lisa Michelle Parker.
An empirical ethics analysis of breast cancer screening in Australia. 7-Mar-2016 Thesis: Kristen Pickles. Prostate cancer screening in primary care: Doctors’ perspectives on prostate-specific antigen (PSA) testing of asymptomatic men in Australia and the United Kingdom.